Pacemaker lead thrombosis – a rare cause of breathlessness
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
https://orcid.org/0009-0008-9292-3756
Alexander Davidson
Kirsty Griffiths
Renzo Pessotto
Stephen James Leslie
Abstract
As the number of pacemaker insertions increases to manage numerous cardiac arrhythmias, the number of complications is also increasing as a result. More common complications such as infection and lead displacement are routinely discussed with patients before they undergo the procedure. However rare complications such as superior vena cava syndrome are not discussed during the consenting period. But they do occur, as seen in this case of a 69-year-old male. This fit and active man had a right-sided dual-chamber pacemaker inserted due to sinus node disease and presented 5 years later with symptoms suggestive of superior vena cava obstruction (SVCO). Despite anticoagulation and before surgical intervention could be performed, the patient developed a right-sided chylothorax which was drained. An autologous pericardial patch repair of the SVC and a thrombectomy of SVC clots was subsequently performed. This was only partially successful and the SVCO recurred. A low fatty chain diet was initiated to manage the chylothorax, which remains stable. This rare complication has left the patient with a small pleural effusion and chronic pleural thickening. They can still exercise with mild breathlessness. The management of such a complication, which requires the input of many specialists, is challenging and often does not completely resolve all symptoms. For this reason, superior vena cava obstruction should be considered as a risk during the consenting procedure for a pacemaker insertion.
##plugins.themes.bootstrap3.article.details##
Chylothorax, pacemaker, SVCO, pleural effusion, complication.
2. Klop B, Scheffer MG, McFadden E, Bracke F, van Gelder B. Treatment of pacemaker-induced superior vena cava syndrome by balloon angioplasty and stenting. Neth Heart J. 2011 Jan;19(1):41-6. doi: 10.1007/s12471-010-0052-6. PMID: 22020858; PMCID: PMC3077837.
3. Cohen R, Mena D, Carbajal-Mendoza R, Matos N, Karki N. Superior vena cava syndrome: A medical emergency? Int J Angiol. 2008 Spring;17(1):43-6. doi: 10.1055/s-0031-1278280. PMID: 22477372; PMCID: PMC2728369.
4. Huang W, Chen Y, Liu Z, Huang Y, Hu Y. Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant. Thromb J. 2023 Feb 13;21(1):19. doi: 10.1186/s12959-023-00459-6. PMID: 36782246; PMCID: PMC9926563.
5. Teo N, Sabharwal T, Rowland E, Curry P, Adam A. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J. 2002 Sep;23(18):1465-70. doi: 10.1053/euhj.2002.3260. PMID: 12208227.
6. Rudrappa M, Paul M. Chylothorax [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Mar 8]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459206/#
7. Townsend T. Five common permanent cardiac pacemaker complications. Nursing Critical Care. 13(4):p 46-48, July 2018. | doi: 10.1097/01.CCN.0000534926.85924.91
8. Senthilvel E, Papadakis A, Jain V, Bruner J. Pacemaker induced superior vena cava syndrome: a case report. Cases J. 2009 Jul 29;2:6463. doi: 10.4076/1757-1626-2-6463. PMID: 19829810; PMCID: PMC2740218.
9. Singh M, Talab SK. A case of pacing lead induced clinical superior vena cava syndrome: a case report. Cases J. 2009 Jun 23;2:7477. doi: 10.4076/1757-1626-2-7477. PMID: 19829974; PMCID: PMC2740201.
10. Riva N, Ageno W. Direct oral anticoagulants for unusual-site venous thromboembolism. Res Pract Thromb Haemost. 2021 Jan 28;5(2):265-277. doi: 10.1002/rth2.12480. PMID: 33733025; PMCID: PMC7938617.
11. Santra A, Nandi S, Mondal S, Chakraborty S. Superior Vena Cava Syndrome due to Thrombosis: A Rare Paraneoplastic Presentation of Bronchogenic Carcinoma. Iran J Med Sci. 2016 Jul;41(4):354-8. PMID: 27365560; PMCID: PMC4912657.
12. Sikorska J, Uprichard J. Direct Oral Anticoagulants: A Quick Guide. Eur Cardiol. 2017 Aug;12(1):40-45. doi: 10.15420/ecr.2017:11:2. PMID: 30416551; PMCID: PMC6206466.
13. Boarescu PM, Roşian AN, Roşian ŞH. Transvenous Lead Extraction Procedure-Indications, Methods, and Complications. Biomedicines. 2022 Nov 1;10(11):2780. doi: 10.3390/biomedicines10112780. PMID: 36359300; PMCID: PMC9687878.
14. Vouliotis AI, Roberts PR, Dilaveris P, et al. Leadless Pacemakers: Current Achievements and Future Perspectives. Eur Cardiol. 2023 Aug 18;18:e49. doi: 10.15420/ecr.2022.32. PMID: 37655133; PMCID: PMC10466270.
15. Sengupta S. Post-operative pulmonary complications after thoracotomy. Indian J Anaesth. 2015 Sep;59(9):618-26. doi: 10.4103/0019-5049.165852. PMID: 26556921; PMCID: PMC4613409.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.